Skip to main navigation Skip to search Skip to main content

New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells

  • Iwao Ojima
  • , Pierre Yves Bounaud
  • , Craig Takeuchi
  • , Paula Pera
  • , Ralph J. Bernacki
  • Stony Brook University
  • Roswell Park Cancer Institute

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

New non-cytotoxic taxanes synthesized from 10-deacetylbaccatin III and special hydrophobic acylating agents show remarkable MDR reversal activity (≤99.8%) against drug-resistant human breast cancer cells when co-administered with paclitaxel or doxorubicin. This activity is ascribed to the highly efficient blocking of P-glycoprotein efflux by these new taxanes.

Original languageEnglish
Pages (from-to)189-194
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume8
Issue number2
DOIs
StatePublished - Jan 20 1998

Fingerprint

Dive into the research topics of 'New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells'. Together they form a unique fingerprint.

Cite this